Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 266

1.

[Non-publication is common among phase 1, single-center, not prospectively registered, or early terminated clinical drug trials].

van den Bogert CA, Souverein PC, Brekelmans CTM, Janssen SWJ, Koëter GH, Leufkens HGM, Bouter LM.

Ned Tijdschr Geneeskd. 2017;161:D1498. Dutch.

PMID:
28659210
2.

Primary endpoint discrepancies were found in one in ten clinical drug trials. Results of an inception cohort study.

van den Bogert CA, Souverein PC, Brekelmans CTM, Janssen SWJ, Koëter GH, Leufkens HGM, Bouter LM.

J Clin Epidemiol. 2017 Sep;89:199-208. doi: 10.1016/j.jclinepi.2017.05.012. Epub 2017 May 20.

PMID:
28535887
3.

Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands.

van den Bogert CA, Souverein PC, Brekelmans CTM, Janssen SWJ, Koëter GH, Leufkens HGM, Bouter LM.

J Clin Epidemiol. 2017 Aug;88:140-147. doi: 10.1016/j.jclinepi.2017.05.001. Epub 2017 May 6.

PMID:
28487159
4.

Non-Publication Is Common among Phase 1, Single-Center, Not Prospectively Registered, or Early Terminated Clinical Drug Trials.

van den Bogert CA, Souverein PC, Brekelmans CT, Janssen SW, Koëter GH, Leufkens HG, Bouter LM.

PLoS One. 2016 Dec 14;11(12):e0167709. doi: 10.1371/journal.pone.0167709. eCollection 2016.

5.

Occurrence and determinants of selective reporting of clinical drug trials: design of an inception cohort study.

van den Bogert CA, Souverein PC, Brekelmans CT, Janssen SW, van Hunnik M, Koëter GH, Leufkens HG, Bouter LM.

BMJ Open. 2015 Jul 7;5(7):e007827. doi: 10.1136/bmjopen-2015-007827.

6.

Regulatory watch: Outcomes of EMA marketing authorization applications: does partnering have an influence?

van den Bogert CA, Souverein PC, Putzeist M, Leufkens HG, Janssen SW, Koëter GH.

Nat Rev Drug Discov. 2014 Dec;13(12):878. doi: 10.1038/nrd4468. Epub 2014 Nov 14. No abstract available.

PMID:
25394870
7.

[Review of multicentre clinical trials is simplified; more trial centres are approved in the first assessment round].

Heringa JW, Al MD, Koëter GH.

Ned Tijdschr Geneeskd. 2014;158:A7558. Dutch.

PMID:
24846116
8.

[Patient safety in clinical intervention research].

Brekelmans CT, Kenter MJ, Bouter LM, Koëter GH.

Ned Tijdschr Geneeskd. 2011;155:A2359. Dutch.

PMID:
21342593
9.

Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation.

Bathoorn E, Liesker JJ, Postma DS, Koëter GH, van der Toorn M, van der Heide S, Ross HA, van Oosterhout AJ, Kerstjens HA.

Int J Chron Obstruct Pulmon Dis. 2009;4:101-9. Epub 2009 Apr 15.

10.

Lipid-soluble components in cigarette smoke induce mitochondrial production of reactive oxygen species in lung epithelial cells.

van der Toorn M, Rezayat D, Kauffman HF, Bakker SJ, Gans RO, Koëter GH, Choi AM, van Oosterhout AJ, Slebos DJ.

Am J Physiol Lung Cell Mol Physiol. 2009 Jul;297(1):L109-14. doi: 10.1152/ajplung.90461.2008. Epub 2009 May 1.

11.

Cross-sectional assessment of daily physical activity in chronic obstructive pulmonary disease lung transplant patients.

Bossenbroek L, ten Hacken NH, van der Bij W, Verschuuren EA, Koëter GH, de Greef MH.

J Heart Lung Transplant. 2009 Feb;28(2):149-55. doi: 10.1016/j.healun.2008.11.905.

PMID:
19201340
12.

Depressive symptoms as predictors of mortality in patients with COPD.

de Voogd JN, Wempe JB, Koëter GH, Postema K, van Sonderen E, Ranchor AV, Coyne JC, Sanderman R.

Chest. 2009 Mar;135(3):619-625. doi: 10.1378/chest.08-0078. Epub 2008 Nov 24.

PMID:
19029432
13.

Transmission of Mycobacterium pinnipedii to humans in a zoo with marine mammals.

Kiers A, Klarenbeek A, Mendelts B, Van Soolingen D, Koëter G.

Int J Tuberc Lung Dis. 2008 Dec;12(12):1469-73.

PMID:
19017459
14.

Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations.

Bathoorn E, Liesker JJ, Postma DS, Boorsma M, Bondesson E, Koëter GH, Kauffman HF, van Oosterhout AJ, Kerstjens HA.

COPD. 2008 Oct;5(5):282-90. doi: 10.1080/15412550802363360.

PMID:
18972276
15.

FVC to slow inspiratory vital capacity ratio: a potential marker for small airways obstruction.

Cohen J, Postma DS, Vink-Klooster K, van der Bij W, Verschuuren E, Ten Hacken NH, Koëter GH, Douma WR.

Chest. 2007 Oct;132(4):1198-203. Epub 2007 Sep 21.

PMID:
17890480
16.

Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study.

Bathoorn E, Slebos DJ, Postma DS, Koeter GH, van Oosterhout AJ, van der Toorn M, Boezen HM, Kerstjens HA.

Eur Respir J. 2007 Dec;30(6):1131-7. Epub 2007 Aug 22.

17.

Cyclosporin A-induced oxidative stress is not the consequence of an increase in mitochondrial membrane potential.

van der Toorn M, Kauffman HF, van der Deen M, Slebos DJ, Koëter GH, Gans RO, Bakker SJ.

FEBS J. 2007 Jun;274(12):3003-12. Epub 2007 May 17.

18.

Safety of sputum induction during exacerbations of COPD.

Bathoorn E, Liesker J, Postma D, Koëter G, van Oosterhout AJ, Kerstjens HA.

Chest. 2007 Feb;131(2):432-8.

PMID:
17296644
19.

Cigarette smoke-induced blockade of the mitochondrial respiratory chain switches lung epithelial cell apoptosis into necrosis.

van der Toorn M, Slebos DJ, de Bruin HG, Leuvenink HG, Bakker SJ, Gans RO, Koëter GH, van Oosterhout AJ, Kauffman HF.

Am J Physiol Lung Cell Mol Physiol. 2007 May;292(5):L1211-8. Epub 2007 Jan 5.

20.

Limiting factors of exercise performance 1 year after lung transplantation.

Reinsma GD, ten Hacken NH, Grevink RG, van der Bij W, Koëter GH, van Weert E.

J Heart Lung Transplant. 2006 Nov;25(11):1310-6.

PMID:
17097494
21.

[Improved exercise tolerance can be achieved in chronic obstructive pulmonary disease (COPD) by means of non-pharmacological treatment].

Wijkstra PJ, Wempe JB, van der Bij W, Klinkenberg T, ten Hacken NH, Köeter GH.

Ned Tijdschr Geneeskd. 2006 Jun 3;150(22):1213-7. Dutch.

PMID:
16796170
22.

Prevotella bivia necrobacillosis following infectious mononucleosis.

Huits RM, van Assen S, Wildeboer-Veloo AC, Verschuuren EA, Koeter GH.

J Infect. 2006 Aug;53(2):e59-63. Epub 2005 Nov 28.

PMID:
16316686
23.

Changes in personal control as a predictor of quality of life after pulmonary rehabilitation.

Arnold R, Ranchor AV, Koëter GH, de Jongste MJ, Wempe JB, ten Hacken NH, Otten V, Sanderman R.

Patient Educ Couns. 2006 Apr;61(1):99-108. Epub 2005 Oct 26.

PMID:
16256290
24.

The relationship between self-efficacy and self-reported physical functioning in chronic obstructive pulmonary disease and chronic heart failure.

Arnold R, Ranchor AV, DeJongste MJ, Köeter GH, Ten Hacken NH, Aalbers R, Sanderman R.

Behav Med. 2005 Fall;31(3):107-15.

PMID:
16252622
25.

Incomplete quality of life data in lung transplant research: comparing cross sectional, repeated measures ANOVA, and multi-level analysis.

Vermeulen KM, Post WJ, Span MM, van der Bij W, Koëter GH, TenVergert EM.

Respir Res. 2005 Sep 8;6:101.

26.

Stress, psychological distress, and coping in patients on the waiting list for lung transplantation: an exploratory study.

Vermeulen KM, Bosma OH, Bij Wv, Koëter GH, Tenvergert EM.

Transpl Int. 2005 Aug;18(8):954-9.

27.

First study of infliximab treatment in patients with chronic obstructive pulmonary disease.

van der Vaart H, Koëter GH, Postma DS, Kauffman HF, ten Hacken NH.

Am J Respir Crit Care Med. 2005 Aug 15;172(4):465-9. Epub 2005 Jun 3.

PMID:
15937294
28.

Consequences of chronic obstructive pulmonary disease and chronic heart failure: the relationship between objective and subjective health.

Arnold R, Ranchor AV, Koëter GH, de Jongste MJ, Sanderman R.

Soc Sci Med. 2005 Nov;61(10):2144-54.

PMID:
15927333
29.

Airway cellular response to two different immunosuppressive regimens in lung transplant recipients.

Slebos DJ, Kauffman HF, Koëter GH, Verschuuren EA, Bij W, Postma DS.

Clin Transplant. 2005 Apr;19(2):243-9. Erratum in: Clin Transplant. 2007 Mar-Apr;21(2):294.

PMID:
15740562
30.

Childhood factors associated with asthma remission after 30 year follow up.

Vonk JM, Postma DS, Boezen HM, Grol MH, Schouten JP, Koëter GH, Gerritsen J.

Thorax. 2004 Nov;59(11):925-9.

31.

Heme oxygenase-1 expression in alveolar macrophages is elevated in patients with bronchiolitis obliterans syndrome after lung transplantation.

Slebos DJ, Kauffman HF, Dijkhuizen B, Zonderland J, Koëter GH, van der Bij W, Postma DS.

J Heart Lung Transplant. 2004 Oct;23(10):1213-4. No abstract available.

PMID:
15477118
32.

Feasibility of sputum induction in lung transplant recipients.

van den Berg JW, Slebos DJ, Postma DS, Dijkhuizen B, Koëter GH, Timens W, der van Bij W, Kauffman HF.

Clin Transplant. 2004 Oct;18(5):605-12.

PMID:
15344968
33.

Bronchoalveolar lavage in a patient with recurrence of sarcoidosis after lung transplantation.

Slebos DJ, Verschuuren EA, Koëter GH, van der Bij W, Kauffman HF, Postma DS, Timens W.

J Heart Lung Transplant. 2004 Aug;23(8):1010-3.

PMID:
15312833
34.

The effect of bronchiolitis obliterans syndrome on health related quality of life.

Vermeulen KM, Groen H, van der Bij W, Erasmus ME, Koëter GH, TenVergert EM.

Clin Transplant. 2004 Aug;18(4):377-83.

PMID:
15233813
35.

Cost-effectiveness of lung transplantation in relation to type of end-stage pulmonary disease.

Groen H, van der Bij W, Koëter GH, TenVergert EM.

Am J Transplant. 2004 Jul;4(7):1155-62.

36.

PET for the evaluation of pleural thickening observed on CT.

Kramer H, Pieterman RM, Slebos DJ, Timens W, Vaalburg W, Koëter GH, Groen HJ.

J Nucl Med. 2004 Jun;45(6):995-8.

37.

Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection.

Slebos DJ, Postma DS, Koëter GH, Van Der Bij W, Boezen M, Kauffman HF.

J Heart Lung Transplant. 2004 May;23(5):532-40.

PMID:
15135367
38.

Improved quality of life after lung transplantation in individuals with cystic fibrosis.

Vermeulen KM, van der Bij W, Erasmus ME, Duiverman EJ, Koëter GH, TenVergert EM.

Pediatr Pulmonol. 2004 May;37(5):419-26.

PMID:
15095325
39.

Endoscopic ultrasound-guided fine-needle aspiration in patients with mediastinal abnormalities and previous extrathoracic malignancy.

Kramer H, Koëter GH, Sleijfer DT, van Putten JW, Groen HJ.

Eur J Cancer. 2004 Mar;40(4):559-62.

PMID:
14962723
40.

The value of ventilation scintigraphy after single lung transplantation.

Ouwens JP, van der Bij W, van der Mark TW, Geertsma A, Piers DA, de Boer WJ, Koëter GH.

J Heart Lung Transplant. 2004 Jan;23(1):115-21.

PMID:
14734136
41.

Provocation with adenosine 5'-monophosphate, but not methacholine, induces sputum eosinophilia.

van den Berge M, Kerstjens HA, de Reus DM, Koëter GH, Kauffman HF, Postma DS.

Clin Exp Allergy. 2004 Jan;34(1):71-6.

PMID:
14720265
42.

Reproducibility and responsiveness of a noninvasive EMG technique of the respiratory muscles in COPD patients and in healthy subjects.

Duiverman ML, van Eykern LA, Vennik PW, Koëter GH, Maarsingh EJ, Wijkstra PJ.

J Appl Physiol (1985). 2004 May;96(5):1723-9. Epub 2003 Dec 5.

43.

Sputum induction in research: beware of the beast.

van den Berg JW, Kerstjens H, Postma D, van der Bij W, Koëter G.

Am J Respir Crit Care Med. 2003 Nov 15;168(10):1253. No abstract available.

PMID:
14607825
44.
45.

Long-term quality of life in patients surviving at least 55 months after lung transplantation.

Vermeulen KM, Ouwens JP, van der Bij W, de Boer WJ, Koëter GH, TenVergert EM.

Gen Hosp Psychiatry. 2003 Mar-Apr;25(2):95-102.

PMID:
12676422
46.

Provocation with adenosine 5'-monophosphate increases sputum eosinophils.

van den Berge M, Kerstjens HA, de Reus DM, Kauffman HF, Koëter GH, Postma DS.

Chest. 2003 Mar;123(3 Suppl):417S. Review. No abstract available.

PMID:
12629008
47.

The cost effectiveness of lung transplantation compared with that of heart and liver transplantation in the Netherlands.

Ouwens JP, van Enckevort PJ, TenVergert EM, Bonsel GJ, van der Bij W, Haagsma EB, Rutten FF, Slooff MJ, Koëter GH.

Transpl Int. 2003 Feb;16(2):123-7. Epub 2003 Jan 14.

PMID:
12595974
48.

Size matching in lung transplantation using predicted total lung capacity.

Ouwens JP, van der Mark TW, van der Bij W, Geertsma A, de Boer WJ, Koëter GH.

Eur Respir J. 2002 Dec;20(6):1419-22.

49.

Peripheral muscle force and exercise capacity in lung transplant candidates.

Van Der Woude BT, Kropmans TJ, Douma KW, Van Der Bij W, Ouwens JP, Koeter GH, Van Der Schans CP.

Int J Rehabil Res. 2002 Dec;25(4):351-5. No abstract available.

PMID:
12451312
50.

Bronchiolar airflow impairment after lung transplantation: an early and common manifestation.

Ouwens JP, van der Mark TW, Koëter GH, de Boer WJ, Grevink RG, van der Bij W.

J Heart Lung Transplant. 2002 Oct;21(10):1056-61.

PMID:
12398869

Supplemental Content

Loading ...
Support Center